Adjuvant Breast Cancer Treatments Cardiotoxicity and Modern Methods of Detection and Prevention of Cardiac Complications
Key result
Modern imaging techniques, cardio-specific biomarkers, and genotyping may identify breast cancer patients at risk of developing treatment-induced cardiotoxicity.
Why the study?
Improved breast cancer survival has led to more frequent cardiotoxic organ complications, warranting a critical assessment of cardiotoxicity and modern detection methods.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Increasing cardiotoxicity burden accompanies longer breast cancer survival; leaves open standardized prevention and monitoring protocols.
Structured PICO
P
Population
Female population with breast cancer undergoing oncological therapy (systemic treatment and radiotherapy)
E
Exposure
Adjuvant breast cancer treatments and methods of detection/prevention of cardiac complications (biomarkers, Global Longitudinal Strain, Three-Dimensional Left Ventricular Ejection Fraction, and genotyping)
O
Outcome
Cardiotoxicity and methods of its detection
The combined use of novel biomarkers, advanced imaging (GLS, 3D LVEF), and genotyping may improve the identification of breast cancer patients at risk for therapy-induced cardiotoxicity.
Cite This Study
Bikiewicz et al. (2021) conducted a review in Breast cancer. Adjuvant breast cancer treatments was evaluated. Modern imaging techniques, cardio-specific biomarkers, and genotyping may identify breast cancer patients at risk of developing treatment-induced cardiotoxicity.